GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.3098
+0.0080 (2.65%)
Aug 28, 2026, 11:44 AM EDT - Market open
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $13.97 million as of August 28, 2026. Its market cap has increased by 240.85% in one year.
Market Cap
13.97M
Enterprise Value
9.01M
1-Year Change
240.85%
Ranking
Category
Stock Price
$0.31
ChartMarket Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $13.97M, a decrease of -83.20%. That is a compound annual growth rate of -19.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 13.97M | 68.37% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 15.51M |
| Adial Pharmaceuticals | 14.94M |
| AEON Biopharma | 14.66M |
| Moolec Science | 14.56M |
| Intensity Therapeutics | 13.94M |
| Passage Bio | 13.93M |
| SeaStar Medical Holding | 13.66M |
| Moleculin Biotech | 13.41M |